These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

220 related items for PubMed ID: 16491037

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Intravitreal triamcinolone acetonide for macular oedema owing to retinal vein occlusion.
    Patel PJ, Zaheer I, Karia N.
    Eye (Lond); 2008 Jan; 22(1):60-4. PubMed ID: 16902493
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Intravitreal triamcinolone acetonide as treatment of macular edema in central retinal vein occlusion.
    Jonas JB, Kreissig I, Degenring RF.
    Graefes Arch Clin Exp Ophthalmol; 2002 Sep; 240(9):782-3. PubMed ID: 12271378
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Intravitreal triamcinolone acetonide for cystoid macular edema in nonischemic central retinal vein occlusion.
    Williamson TH, O'Donnell A.
    Am J Ophthalmol; 2005 May; 139(5):860-6. PubMed ID: 15860292
    [Abstract] [Full Text] [Related]

  • 12. Intravitreal triamcinolone acetonide for treatment of intraocular oedematous and neovascular diseases.
    Jonas JB.
    Acta Ophthalmol Scand; 2005 Dec; 83(6):645-63. PubMed ID: 16396641
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. One-year safety and efficacy of intravitreal triamcinolone acetonide for the management of macular edema secondary to central retinal vein occlusion.
    Gregori NZ, Rosenfeld PJ, Puliafito CA, Flynn HW, Lee JE, Mavrofrides EC, Smiddy WE, Murray TG, Berrocal AM, Scott IU, Gregori G.
    Retina; 2006 Oct; 26(8):889-95. PubMed ID: 17031288
    [Abstract] [Full Text] [Related]

  • 15. Intravitreal versus retrobulbar injections of triamcinolone for macular edema associated with branch retinal vein occlusion.
    Hayashi K, Hayashi H.
    Am J Ophthalmol; 2005 Jun; 139(6):972-82. PubMed ID: 15953425
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Macular star secondary to nasal branch retinal vein occlusion.
    Parodi MB, Iacono P, Ravalico G.
    Ophthalmic Surg Lasers Imaging; 2009 Jun; 40(5):504-5. PubMed ID: 19772278
    [Abstract] [Full Text] [Related]

  • 18. Anatomic and visual outcomes of noninfectious endophthalmitis after intravitreal triamcinolone.
    Yoon SJ, Rhee DY, Marx JL, Blaha GR, Rogers AH, Baumal CR, Reichel E, Duker JS.
    Am J Ophthalmol; 2009 Jun; 147(6):1031-6. PubMed ID: 19268893
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Infectious and noninfectious endophthalmitis after intravitreal high-dosage triamcinolone acetonide.
    Lorenzo Carrero J, Pérez Flores I, González Barcia M.
    Am J Ophthalmol; 2006 Sep; 142(3):529; author reply 529-30. PubMed ID: 16935616
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.